Guelph, ON

October 27, 2021

ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC:ZENYF), a Canadian, intellectual property development company focused on next-gen healthcare solutions, is pleased to announce that it has filed articles of amendment to change its name to “Zentek Ltd.” (the “Name Change”). The Name Change was approved by shareholders of the Company at its annual and special meeting held on September 27, 2021.  The Common Shares are expected to commence trading on the TSX Venture Change under the new name “Zentek Ltd.” on or about November 1, 2021. The Company’s symbol will remain “ZEN”.  A new CUSIP number has been obtained to replace the previous CUSIP number.
No action will be required by existing shareholders with respect to the Name Change. Certificates representing common shares of the Company will not be affected by the Name Change and will not need to be exchanged. The Company encourages any shareholder with any questions or concerns to contact the Company or to discuss any of the foregoing with their broker or agent.
 
About ZEN Graphene Solutions Ltd.
 
ZEN is an intellectual property development company developing and commercializing next-gen healthcare solutions in the areas of prevention, detection, and treatment. ZEN is currently focused on commercializing ZENGuardTM, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The Company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology. 
  
For further information: 
Matt Blazei 
Tel: (212) 655-0924 
Email: mattb@coreir.com
 
To find out more about ZEN Graphene Solutions Ltd., please visit our website at www.ZENGraphene.com. A copy of this news release and all material documents in respect of the Company may be obtained on ZEN’s SEDAR profile at www.sedar.ca.